| Literature DB >> 35882380 |
Ankit D Kanthe1,2, Miriam R Carnovale3, Joshua S Katz3, Susan Jordan3, Mary E Krause1, Songyan Zheng1, Andrew Ilott1, William Ying1, Wei Bu4, Mrinal K Bera4, Binhua Lin4, Charles Maldarelli2,5, Raymond S Tu2.
Abstract
Protein adsorption on surfaces can result in loss of drug product stability and efficacy during the production, storage, and administration of protein-based therapeutics. Surface-active agents (excipients) are typically added in protein formulations to prevent undesired interactions of proteins on surfaces and protein particle formation/aggregation in solution. The objective of this work is to understand the molecular-level competitive adsorption mechanism between the monoclonal antibody (mAb) and a commercially used excipient, polysorbate 80 (PS80), and a novel excipient, N-myristoyl phenylalanine-N-polyetheramine diamide (FM1000). The relative rate of adsorption of PS80 and FM1000 was studied by pendant bubble tensiometry. We find that FM1000 saturates the interface faster than PS80. Additionally, the surface-adsorbed amounts from X-ray reflectivity (XRR) measurements show that FM1000 blocks a larger percentage of interfacial area than PS80, indicating that a lower bulk FM1000 surface concentration is sufficient to prevent protein adsorption onto the air/water interface. XRR models reveal that with an increase in mAb concentration (0.5-2.5 mg/mL: IV based formulations), an increased amount of PS80 concentration (below critical micelle concentration, CMC) is required, whereas a fixed value of FM1000 concentration (above its relatively lower CMC) is sufficient to inhibit mAb adsorption, preventing mAb from co-existing with surfactants on the surface layer. With this observation, we show that the CMC of the surfactant is not the critical factor to indicate its ability to inhibit protein adsorption, especially for chemically different surfactants, PS80 and FM1000. Additionally, interface-induced aggregation studies indicate that at minimum surfactant concentration levels in protein formulations, fewer protein particles form in the presence of FM1000. Our results provide a mechanistic link between the adsorption of mAbs at the air/water interface and the aggregation induced by agitation in the presence of surfactants.Entities:
Keywords: FM1000; X-ray reflectivity; air/water interface; monoclonal antibody (mAb); novel surfactants; pendant bubble tensiometry; polysorbate 80 (PS80); protein aggregation; protein formulations; silicone oil/liquid interface; surface tension
Mesh:
Substances:
Year: 2022 PMID: 35882380 PMCID: PMC9450885 DOI: 10.1021/acs.molpharmaceut.2c00152
Source DB: PubMed Journal: Mol Pharm ISSN: 1543-8384 Impact factor: 5.364